Superb Micro-vascular Imaging (SMI) based on the iBeam platform is used to evaluate the blood supply of solid tumors. Compared with color Doppler technology, the sensitivity, accuracy and consistency of the ability of SMI to display blood flow are evaluated. Thus, the investigators will use Superb-Microvascular imaging (SMI, Toshiba, Japan) for diagnosing hepatic lesions, which enable to detect slow micro vascular flow inside the tumor
To evaluate the diagnostic accuracy of SMI (primary outcome) when applying on the hepatic lesion. Each US findings during exam for patients with hepatic lesion were recorded by radiologist. Sample size calculation according to the primary outcome.
Study Type
OBSERVATIONAL
Enrollment
150
Device: Superb-Microvascular imaging Superb-Microvascular imaging: new sonographic software technique on ultrasonography to detect low-vascular flow without use of contrast media for ultrasonography
The second affilliated hospital of Zhejiang University school of medicine
Hangzhou, Zhejiang, China
RECRUITINGdiagnostic accuracy
Time frame: 1 week preoperatively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.